Literature DB >> 2173908

Expression of epidermal-growth-factor receptor in the K562 cell line by transfection. Altered receptor biochemistry.

H Allen1, J Hsuan, S Clark, R Maziarz, M D Waterfield, R A Flavell, J Haley.   

Abstract

The epidermal-growth-factor (EGF) receptor was expressed in the human erythroleukaemic cell line K562 by transfection of the receptor cDNA. EGF-receptor biochemistry appears altered in the K562 transfectants. Autophosphorylation of the K562 receptor is not stimulated substantially by EGF. Tyrosine kinase activity of the receptor is high in the absence of EGF, whereas receptor affinity for EGF is low. K562 cells are shown to lack mRNA for transforming growth factor alpha (TGF alpha). Therefore autocrine stimulation of the K562 receptor, at least by TGF alpha, does not explain the observed receptor biochemistry. The K562 receptor is phosphorylated at a single major site in intact cells, a threonine residue that may be Thr-669. Possible mechanisms of regulation of the EGF receptor in the K562 transfectants are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173908      PMCID: PMC1149632          DOI: 10.1042/bj2710785

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Rapid isolation of plasma membranes in high yield from cultured fibroblasts.

Authors:  D Thom; A J Powell; C W Lloyd; D A Rees
Journal:  Biochem J       Date:  1977-11-15       Impact factor: 3.857

2.  Structure and function of human amphiregulin: a member of the epidermal growth factor family.

Authors:  M Shoyab; G D Plowman; V L McDonald; J G Bradley; G J Todaro
Journal:  Science       Date:  1989-02-24       Impact factor: 47.728

3.  Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein.

Authors:  G Q Daley; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Group-specific human granulocyte antigens on a chronic myelogenous leukemia cell line with a Philadelphia chromosome marker.

Authors:  S I Drew; P I Terasaki; R J Billing; O J Bergh; J Minowada; E Klein
Journal:  Blood       Date:  1977-05       Impact factor: 22.113

5.  Identification of two human beta-tubulin isotypes.

Authors:  J L Hall; L Dudley; P R Dobner; S A Lewis; N J Cowan
Journal:  Mol Cell Biol       Date:  1983-05       Impact factor: 4.272

6.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

7.  Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes.

Authors:  H Ushiro; S Cohen
Journal:  J Biol Chem       Date:  1980-09-25       Impact factor: 5.157

8.  The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity.

Authors:  G D Plowman; J M Green; V L McDonald; M G Neubauer; C M Disteche; G J Todaro; M Shoyab
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

9.  A monoclonal antibody to the human epidermal growth factor receptor.

Authors:  M D Waterfield; E L Mayes; P Stroobant; P L Bennet; S Young; P N Goodfellow; G S Banting; B Ozanne
Journal:  J Cell Biochem       Date:  1982       Impact factor: 4.429

10.  Truncation of the human EGF receptor leads to differential transforming potentials in primary avian fibroblasts and erythroblasts.

Authors:  K Khazaie; T J Dull; T Graf; J Schlessinger; A Ullrich; H Beug; B Vennström
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

View more
  4 in total

1.  Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo.

Authors:  Liujiang Song; M Ariel Kauss; Etana Kopin; Manasa Chandra; Taihra Ul-Hasan; Erin Miller; Giridhara R Jayandharan; Angela E Rivers; George V Aslanidi; Chen Ling; Baozheng Li; Wenqin Ma; Xiaomiao Li; Lourdes M Andino; Li Zhong; Alice F Tarantal; Mervin C Yoder; Kamehameha K Wong; Mengqun Tan; Saswati Chatterjee; Arun Srivastava
Journal:  Cytotherapy       Date:  2013-08       Impact factor: 5.414

2.  Lapatinib induces autophagy, apoptosis and megakaryocytic differentiation in chronic myelogenous leukemia K562 cells.

Authors:  Huey-Lan Huang; Yu-Chieh Chen; Yu-Chuen Huang; Kai-Chien Yang; Hsin yi Pan; Shou-Ping Shih; Yu-Jen Chen
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

3.  Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia.

Authors:  Yu-Jen Chen; Li-Wen Fang; Wen-Chi Su; Wen-Yi Hsu; Kai-Chien Yang; Huey-Lan Huang
Journal:  Onco Targets Ther       Date:  2016-07-20       Impact factor: 4.147

4.  High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo.

Authors:  Liujiang Song; Xiaomiao Li; Giridhara R Jayandharan; Yuan Wang; George V Aslanidi; Chen Ling; Li Zhong; Guangping Gao; Mervin C Yoder; Changquan Ling; Mengqun Tan; Arun Srivastava
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.